Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus - Wikidata - awgldk - TriplyDB

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

http://www.wikidata.org/entity/Q33897901

about

Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.

P2860

Q52630076-C864A572-A529-4932-BB71-1218915C6A32

P2860

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

http://www.wikidata.org/entity/Q33897901

description

2017 nî lūn-bûn

@nan

2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

@ast

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

@en

type

label

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

@ast

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

@en

prefLabel

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

@ast

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

@en

P1433

Q33897901-2530A7BF-D2D4-4004-A110-F9D23CCC428D

P1476

Q33897901-B5AAFE68-A766-48CC-BB94-F58735EE509E

P2093

Q33897901-35D75C89-0FE8-49CD-8EB9-2D126FDEA93F

Q33897901-45C5120B-824E-4EDF-BDC2-2C7E13619BC0

Q33897901-50221F1A-91F4-47D9-BFCD-B0C56D959C22

Q33897901-5BEF6582-5E19-44F2-9314-E8BA9BE88BBB

Q33897901-711EA38C-6077-4C2B-B333-957AE9A0E054

Q33897901-82FB65E6-0F14-4F5F-A1BE-C00D9700D49F

Q33897901-9720C811-5C9C-43D6-8D71-5278DB92D7E2

Q33897901-A0733946-EF3A-4CDD-A6F6-B85C00C0E4E7

Q33897901-B4124BFD-AF65-4B15-9E71-6C6B178E9B5D

Q33897901-B600F866-BEBE-4310-94C6-0521C0ACEE4A

P2860

Q33897901-038B8C40-191E-4693-BB17-C802D8F12EA0

Q33897901-051B94CC-8865-46B7-BBB2-2AE81FD6D72E

Q33897901-05D5CB1C-E5D5-4A29-8829-0A12B19ACF52

Q33897901-06DA5EDC-B18E-4AC9-9D98-8D8C8ECEA4B7

Q33897901-0D109E95-8969-4CB9-BFFE-D131DDB9602A

Q33897901-222B9308-D4A9-430A-A056-9CBC326A011D

Q33897901-294D06B5-70DD-4EF6-8699-F1E56866C127

Q33897901-4CEAEC14-FCD2-4248-B8CE-D3AA480CAFEA

Q33897901-54D653A4-CF77-465F-BB4B-14770D10A6E6

Q33897901-5C51C3EC-B77D-4C38-A9E6-A7D75ACC40CA

P304

Q33897901-490AA17B-B589-4D19-9B3C-468A23789477

P31

Q33897901-1CA351A2-872B-444C-BF9D-7B5D080EED49

P356

Q33897901-8C361418-2898-4CC7-A197-132BCCD61C1C

P407

Q33897901-94C109DD-952A-4C9A-BCDC-2B5C11DE50A0

P433

Q33897901-10B34FD5-47F7-4CA7-B4E0-BBA1AB1E09C2

P478

Q33897901-0A660384-FA77-4789-8499-0E9485977486

P50

Q33897901-20F190F8-BC05-4D71-B5A8-DFFBFCC90FDC

P577

Q33897901-AAA6ED23-A725-4351-886D-A749F84F4230

P698

Q33897901-0FF267AA-8DE3-427F-881F-DB2592EF9D9B

P921

Q33897901-F364092D-A0C6-46D6-BBCB-BB584C2E636A

P932

Q33897901-02F24006-B4E1-4D57-9AF0-988795088F6F

P356

JOURNAL.PONE.0180964

P1433

P1476

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

@en

P2093

Brad H Rovin

http://www.w3.org/2001/XMLSchema#string

CKD Biomarkers Consortium

http://www.w3.org/2001/XMLSchema#string

E Jennifer Weil

http://www.w3.org/2001/XMLSchema#string

Gudeta D Fufaa

http://www.w3.org/2001/XMLSchema#string

Harold I Feldman

http://www.w3.org/2001/XMLSchema#string

Helen C Looker

http://www.w3.org/2001/XMLSchema#string

Jian Cai

http://www.w3.org/2001/XMLSchema#string

Jon B Klein

http://www.w3.org/2001/XMLSchema#string

Kevin M Wheelock

http://www.w3.org/2001/XMLSchema#string

Michael L Merchant

http://www.w3.org/2001/XMLSchema#string

P2860

The kallikrein-kinin system in diabetic nephropathy

International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences

Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy.

Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes.

Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma.

Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice

Kinins and kinin receptors: importance for the activation of leukocytes.

Renal and retinal effects of enalapril and losartan in type 1 diabetes

Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase.

Blockade of the kinin B1 receptor ameloriates glomerulonephritis

P304

e0180964

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0180964

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Ramachandran S. Vasan

P577

2017-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28700653

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

5507314

http://www.w3.org/2001/XMLSchema#string